These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 33580113)

  • 1. Spatio-temporal distribution characteristics and influencing factors of COVID-19 in China.
    Chen Y; Li Q; Karimian H; Chen X; Li X
    Sci Rep; 2021 Feb; 11(1):3717. PubMed ID: 33580113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatio-temporal distribution characteristics of COVID-19 in China: a city-level modeling study.
    Ma Q; Gao J; Zhang W; Wang L; Li M; Shi J; Zhai Y; Sun D; Wang L; Chen B; Jiang S; Zhao J
    BMC Infect Dis; 2021 Aug; 21(1):816. PubMed ID: 34391402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis on the characteristics of spatio-temporal evolution and aggregation trend of early COVID-19 in mainland China.
    Bi S; Bie S; Hu X; Zhang H
    Sci Rep; 2022 Mar; 12(1):4380. PubMed ID: 35288642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020.
    Wang Y; Yu J; Wang F; Zhang Y; Ma S
    Front Public Health; 2023; 11():1151038. PubMed ID: 37089485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the domestic resumption of social production and life under the COVID-19 epidemic.
    Xu X; Wang S; Dong J; Shen Z; Xu S
    PLoS One; 2020; 15(7):e0236387. PubMed ID: 32697812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.
    Ke Y; Cui J; Wong Y
    J Epidemiol Glob Health; 2021 Mar; 11(1):42-45. PubMed ID: 33009735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
    Cheng S; Zhao Y; Kaminga AC; Zhang X; Xu H
    Front Public Health; 2022; 10():548056. PubMed ID: 35844877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographical characteristics and influencing factors of the influenza epidemic in Hubei, China, from 2009 to 2019.
    Yang M; Gong S; Huang S; Huo X; Wang W
    PLoS One; 2023; 18(11):e0280617. PubMed ID: 38011126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial and temporal differentiation of COVID-19 epidemic spread in mainland China and its influencing factors.
    Xie Z; Qin Y; Li Y; Shen W; Zheng Z; Liu S
    Sci Total Environ; 2020 Nov; 744():140929. PubMed ID: 32687995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of COVID-19 in Jiangxi, China: A retrospective observational study.
    Dong Y; Ding S; Zhang J; Liu Y
    Medicine (Baltimore); 2021 Oct; 100(43):e27685. PubMed ID: 34713866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population flow drives spatio-temporal distribution of COVID-19 in China.
    Jia JS; Lu X; Yuan Y; Xu G; Jia J; Christakis NA
    Nature; 2020 Jun; 582(7812):389-394. PubMed ID: 32349120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatio-temporal evolution and influencing mechanism of the COVID-19 epidemic in Shandong province, China.
    Shi J; Gao X; Xue S; Li F; Nie Q; Lv Y; Wang J; Xu T; Du G; Li G
    Sci Rep; 2021 Apr; 11(1):7811. PubMed ID: 33837241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal analysis of COVID-19 outbreaks in Wuhan, China.
    Liu W; Wang D; Hua S; Xie C; Wang B; Qiu W; Xu T; Ye Z; Yu L; Yang M; Xiao Y; Feng X; Shi T; Li M; Chen W
    Sci Rep; 2021 Jul; 11(1):13648. PubMed ID: 34211038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal evolution, pattern of diffusion, and influencing factors of the COVID-19 epidemic in Hainan Province, China.
    Gao X; Li G; Wang J; Xu T
    J Med Virol; 2022 Apr; 94(4):1581-1591. PubMed ID: 34862623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.
    Wu JT; Leung K; Leung GM
    Lancet; 2020 Feb; 395(10225):689-697. PubMed ID: 32014114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal and spatial analysis of COVID-19 transmission in China and its influencing factors.
    Wang Q; Dong W; Yang K; Ren Z; Huang D; Zhang P; Wang J
    Int J Infect Dis; 2021 Apr; 105():675-685. PubMed ID: 33711521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Threshold conditions for curbing COVID-19 with a dynamic zero-case policy derived from 101 outbreaks in China.
    Tang S; Wang X; Tang B; He S; Yan D; Huang C; Shao Y; Xiao Y; Cheke RA
    BMC Public Health; 2023 Jun; 23(1):1084. PubMed ID: 37280554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spatiotemporal evolution of COVID-19 epidemic in the early phase in China].
    Gao R; Yu SC; Wang QQ; Zhou XH; Liu NK; Tan F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Mar; 43(3):297-304. PubMed ID: 35345281
    [No Abstract]   [Full Text] [Related]  

  • 20. Spatio-temporal characteristics and control strategies in the early period of COVID-19 spread: a case study of the mainland China.
    Ning J; Chu Y; Liu X; Zhang D; Zhang J; Li W; Zhang H
    Environ Sci Pollut Res Int; 2021 Sep; 28(35):48298-48311. PubMed ID: 33904137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.